Stefan Wawersik

Stefan Wawersik

Company: Q32 Bio Inc.

Job title: Vice President of Research


Developing Locally Targeted Complement Therapeutics 2:30 pm

Reviewing strategies for locally targeted inhibitors Addressing pharmacology challenges of characterizing locally targeted drugs Discussing the advantages of local targeting – potency, durability, and safetyRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.